Dockets Home | Accessibility | Dockets Contacts and Location | Operating Status | Item Codes

DOCKETS ENTERED on 3/19/03

Docket Number - Title

ANS 2 John M. Taylor, III to J. David Ash, Esq Vol#: 1

LET 12 Satish R. Shah Vol#: 1

LET 13 Christopher B. Mead Vol#: 1

LET 14 Satish R. Shah Vol#: 1

LET 15 Satish R. Shah Vol#: 1

97P-0130 Require Percentage Ingredient Labeling

C 165 JoAnn Witt Vol#: 5

C 166 Judith Watson Vol#: 5

C 167 John J. Saemann Vol#: 5

C 168 Ms. Meg Neustadt Vol#: 5

C 169 Peggy Lane Vol#: 5

00E-1234 Patent Extension for SONATA (zalepon) #4,626,538

AAV 1 US Patent & Trademark Office Vol#: 1

00E-1237 Patent Extension for Relenza (zanamivir), # 5,360,817

AAV 1 US Patent & Trademark Office Vol#: 1

00E-1345 Patent Extension ACTOS, No. 4,687,777

AAV 1 US Patent & Trademark Office Vol#: 1

00N-1571 Enrofloxacin for Poultry: Opportunity for Hearing

CS 31 HFA-305 Vol#: 362

CS 32 HFA-305 Vol#: 362

OR 33 HF-3 Vol#: 362

OR 34 HF-3 Vol#: 362

00P-1322 Food Labeling and Allergen Contamination Control

C 513 Anna Greenleaf Vol#: 29

C 514 Melinda L. Miller Vol#: 29

C 515 Limor Weisberg Vol#: 29

C 516 Catrina Popelier, RN, BSN Vol#: 29

C 517 Sheila Renda Springs Vol#: 29

C 518 The Enger Family Vol#: 29

C 519 David Kaplowitz, MD Vol#: 29

C 520 Joan Dunlap Vol#: 29

C 521 Anne Donath Vol#: 29

C 522 Baptisy Health Center Vol#: 29

C 523 Georgetta Hare Vol#: 29

C 524 Sheila Renda Springs Vol#: 29

01E-0362 Patent Term Extension Application, TRAVATAN No. 5,889,052

AAV 1 US Patent & Trademark Office Vol#: 1

02H-0443 Civil Money Penalty Re: LaHaye Ctr.for Advanced Eye Care

CS 5 HFA-305 Vol#: 1

OR 4 HF-3 Vol#: 1

02N-0204 Bar Code Label Requirements for human drug products

NPR 1 Vol#: 8

02N-0528 Risk Management Workshop, April 9-11, 2003 [PDUFA III]

APE 4 Pharmaceutical Safety Assessments, Inc. Vol#: 1

SUP 1 Pharmaceutical Safety Assessments, Inc. Vol#: 1

02P-0469 ANDA for Brimonidine Tartrate Ophthalmic Solution 0.2%

RC 2 Allergan, Inc. Vol#: 1